La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Insulet Gestion
Gestion contrôle des critères 4/4
Insulet's CEO is Jim Hollingshead, appointed in Jun 2022, has a tenure of 2.17 years. total yearly compensation is $12.38M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.025% of the company’s shares, worth $3.38M. The average tenure of the management team and the board of directors is 2.2 years and 3.8 years respectively.
Informations clés
Jim Hollingshead
Directeur général
US$12.4m
Rémunération totale
| Pourcentage du salaire du PDG | 6.8% |
| Durée du mandat du directeur général | 2.2yrs |
| Propriété du PDG | 0.02% |
| Durée moyenne d'occupation des postes de direction | 2.2yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 3.8yrs |
Mises à jour récentes de la gestion
Recent updates
Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings
Aug 16
A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Jul 15Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Dec 28Insulet: An Overpriced Play In The Medical Space
Oct 18Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$395m |
| Mar 31 2024 | n/a | n/a | US$234m |
| Dec 31 2023 | US$12m | US$842k | US$206m |
| Sep 30 2023 | n/a | n/a | US$120m |
| Jun 30 2023 | n/a | n/a | US$63m |
| Mar 31 2023 | n/a | n/a | US$600k |
| Dec 31 2022 | US$11m | US$440k | US$5m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$45m |
| Dec 31 2021 | US$290k | n/a | US$17m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$259k | n/a | US$7m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$18m |
| Mar 31 2020 | n/a | n/a | US$5m |
| Dec 31 2019 | US$261k | n/a | US$12m |
Rémunération vs marché: Jim's total compensation ($USD12.38M) is about average for companies of similar size in the US market ($USD13.21M).
Rémunération et revenus: Jim's compensation has been consistent with company performance over the past year.
PDG
Jim Hollingshead (61 yo)
2.2yrs
Titularisation
US$12,379,765
Compensation
Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 2.2yrs | US$12.38m | 0.025% $ 3.4m | |
| Group VP | 5.3yrs | US$1.44m | 0.0081% $ 1.1m | |
| Senior VP & CTO | 1.1yrs | US$2.37m | 0.018% $ 2.5m | |
| Senior VP & General Counsel | 5.4yrs | US$2.47m | 0.021% $ 2.9m | |
| Executive VP | 6.5yrs | US$3.14m | 0.024% $ 3.3m | |
| Executive VP | less than a year | pas de données | pas de données | |
| Senior Vice President of Global Operations | 1.6yrs | pas de données | 0.0077% $ 1.0m | |
| Vice President of Investor Relations | 9.6yrs | pas de données | pas de données | |
| Senior VP of Regulatory Affairs | 1.7yrs | pas de données | 0.0044% $ 601.8k | |
| Senior Director of Corporate Communications | no data | pas de données | pas de données | |
| Senior Vice President of Sales & Customer Care | 9.6yrs | pas de données | pas de données | |
| Senior VP of Strategy & Corporate Development | less than a year | pas de données | pas de données |
2.2yrs
Durée moyenne de l'emploi
52yo
Âge moyen
Gestion expérimentée: PODD's management team is considered experienced (2.2 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 5.1yrs | US$12.38m | 0.025% $ 3.4m | |
| Independent Director | 2.5yrs | US$322.50k | 0.0040% $ 536.7k | |
| Independent Chairman | 10yrs | US$387.10k | 0.049% $ 6.6m | |
| Chairman of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Educator Advisory Board | no data | pas de données | pas de données | |
| Member of Educator Advisory Board | no data | pas de données | pas de données | |
| Member of Educator Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Educator Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Independent Director | less than a year | pas de données | pas de données |
3.8yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: PODD's board of directors are considered experienced (3.8 years average tenure).